Keurig Dr Pepper Inc. (KDP) Market Cap & Valuation Ratios
Keurig Dr Pepper Inc. (KDP) has a market cap of $47.2B, a trailing P/E of 35.0 and a price-to-sales ratio of 2.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
KDPKeurig Dr Pepper Inc.Follow KDP — free
—
Price chart with a free account
- Market cap
- 47.2B
- P/E TTM
- 35.0
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Peers
beverages - non-alcoholic · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| KDP | 47 | 35.0 | 3.8 | 18.7 | 4.2% | +27% | 16% | 5% |
| KO | 399 | 27.8 | 8.6 | 27.0 | 3.6% | +7% | 30% | 19% |
| PEP | 185 | 21.4 | 2.3 | 12.1 | 5.7% | +6% | 15% | 19% |
| MNST | 90 | 42.9 | 9.4 | 31.0 | 2.3% | +20% | 29% | 33% |
| CCEP | 50 | — | — | — | — | +2% | 13% | 12% |
| COKE | 14 | — | 2.1 | 13.2 | 4.8% | +11% | 13% | 36% |
| CELH | 7.2 | 123.8 | 2.4 | 36.7 | 6.4% | +83% | 5% | 11% |
| PRMB | 7.1 | 72.9 | 1.8 | 10.8 | 5.1% | +12% | 7% | 4% |
| FIZZ | 3.4 | 19.4 | 2.8 | 13.6 | 4.8% | -2% | 18% | 65% |
| COCO | 3.2 | 28.4 | 4.0 | 19.8 | 4.5% | +26% | 20% | 43% |
| Median of these 9 | 28.4 | 2.6 | 16.7 | 4.8% | +11% | 15% | 19% |
P/E 35.0 vs. a peer median of 28.4; EV/Sales 3.8 vs. 2.6. KDP's own P/E sits at the 98th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesCCEP and COKE have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Keurig Dr Pepper Inc. — questions
- What is Keurig Dr Pepper Inc.'s market cap?
- $47.2B.
- What is Keurig Dr Pepper Inc.'s P/E ratio?
- 35.0 on trailing twelve-month earnings to 2026-06-30.
- What is Keurig Dr Pepper Inc.'s price-to-sales ratio?
- 2.4.
Every figure on this page comes from Keurig Dr Pepper Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.